Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • NPPA to meet top...

    NPPA to meet top Cardiologists, Stent Makers, medical bodies on stent price revision

    Written by Ruby Khatun Khatun Published On 2018-01-30T15:42:10+05:30  |  Updated On 30 Jan 2018 3:42 PM IST
    NPPA to meet top Cardiologists, Stent Makers, medical bodies on stent price revision

    New Delhi: Through a recent notification, National Pharmaceutical Pricing Authority (NPPA), Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India has announced that it will be holding a meeting for stakeholders consultation on revising the ceiling price of Coronary Stents.


    NPPA fixed the ceiling prices of coronary stents vide notification dated 13th February 2017 which was valid for one year. This decision is to be revisited now during February 2018.


    As per an order dated 29th January the Authority in its meeting to be held on 05th February 2018 in the Conference Room of NPPA will hear all the stakeholders.


    On 30th January NPPA will meet eminent Intervention Cardiologists; on 5th Feb will meet AdvaMed, MTal, AIMED, ISMA, AMCCI, AMCHAM, ASSOCHAM, CM, FICCI, PHDCC&I, Multinational stent manufacturing companies, Indian Stent manufacturing companies and ADEH, AIDAN. CAI, ORF, Oxfam India, PHFI.


















    SI NoDateTimeStakeholders
    1.30-01-201803.00 pmMeeting with eminent Intervention Cardiologists

















































    SI NoDateTimeStakeholders
    105-02-201811.30 amAdvaMed, MTaI
    205-02-201812.15 pmAIMED, ISMA
    305-02-201802.30 pmAMCCI, AMCHAM, ASSOCHAM, CII, FICCI, PHDCC&I,
    405-02-201803.15 pmMultinational scent manufacturing companies
    505-02-201804.00 pmIndian Stent manufacturing companies
    605-02-201804.45 pmADEH, AIDAN, CAI, ORF, Oxfam India, PHFI,

    Apart from the above-mentioned stakeholders, if any formal stakeholder has been left out and wants to put forward its views, they are requested to send an email in this regard to chairman.nppa@nic.in for getting confirmation for the meeting.


    Not more than one representative of a company may be allowed.


    In a memorandum dated 9 November 2017 NPPA had asked domestic and foreign stent makers to submit their representations on stent pricing by 31 December 2017. Same month Abbott Laboratories refused to introduce its latest stent Xience Sierra in India. Earlier in September, it had received permission to withdraw its premium Xience Alpine metallic stents as well as its dissolving stents.


    Read also: Abbott pulls back its bioresorbable stent-ABSORB, also moves to withdraw XIENCE from India

    Read also: NPPA says Abbott can discontinue Xience Alpine stent in a year, check out details

    In September, US trade representative wrote to Indian commerce minister and the prime minister’s principal secretary that the policy had created serious problems for US stent makers in India. He also urged India not to extend caps to other devices. The matter was also discussed during Prime Minister Narendra Modi’s visit to Washington in June.


    Below is the attachment for the same.

    http://www.nppaindia.nic.in/order/Stakeholder_consultation.pdf
    AdvaMedceiling priceconsultationCoronary StentsDepartment of PharmaceuticalsFicciGovernment of IndiameetingMinistry of Chemicals and FertilizersMTalNational Pharmaceutical Pricing AuthorityNPPAstakeholders

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok